Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

The interactions of ceftobiprole with purified beta-lactamases from molecular classes A, B, C, and D were determined and compared with those of benzylpenicillin, cephaloridine, cefepime, and ceftazidime. Enzymes were selected from functional groups 1, 2a, 2b, 2be, 2d, 2e, and 3 to represent beta-lactamases from organisms within the antibacterial spectrum of ceftobiprole. Ceftobiprole was refractory to hydrolysis by the common staphylococcal PC1 beta-lactamase, the class A TEM-1 beta-lactamase, and the class C AmpC beta-lactamase but was labile to hydrolysis by class B, class D, and class A extended-spectrum beta-lactamases. Cefepime and ceftazidime followed similar patterns. In most cases, the hydrolytic stability of a substrate correlated with the MIC for the producing organism. Ceftobiprole and cefepime generally had lower MICs than ceftazidime for AmpC-producing organisms, particularly AmpC-overexpressing Enterobacter cloacae organisms. However, all three cephalosporins were hydrolyzed very slowly by AmpC cephalosporinases, suggesting that factors other than beta-lactamase stability contribute to lower ceftobiprole and cefepime MICs against many members of the family Enterobacteriaceae.

Knowledge Graph

Similar Paper

Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D
Antimicrobial Agents and Chemotherapy 2007.0
Interaction of Ceftobiprole with the Low-Affinity PBP 5 of Enterococcus faecium
Antimicrobial Agents and Chemotherapy 2010.0
Binding of Ceftobiprole and Comparators to the Penicillin-Binding Proteins of Escherichia coli , Pseudomonas aeruginosa , Staphylococcus aureus , and Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2007.0
Time-Kill and Synergism Studies of Ceftobiprole against Enterococcus faecalis , Including β-Lactamase-Producing and Vancomycin-Resistant Isolates
Antimicrobial Agents and Chemotherapy 2007.0
Hydrolysis and Inhibition Profiles of β-Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and Meropenem
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections
Antimicrobial Agents and Chemotherapy 2008.0
In Vivo Activity of Ceftobiprole in Murine Skin Infections Due toStaphylococcus aureusandPseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy 2010.0
Affinity of Ceftobiprole for Penicillin-Binding Protein 2b in Streptococcus pneumoniae Strains with Various Susceptibilities to Penicillin
Antimicrobial Agents and Chemotherapy 2010.0
Comparative Study of the Susceptibilities of Major Epidemic Clones of Methicillin-Resistant Staphylococcus aureus to Oxacillin and to the New Broad-Spectrum Cephalosporin Ceftobiprole
Antimicrobial Agents and Chemotherapy 2008.0
Kinetic Study on Cephamycin C Degradation
Applied Biochemistry and Biotechnology 2013.0